Resverlogix Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

LSE:0VF9 Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
16 Nov 23SellCA$5,344Aaron CannIndividual76,000CA$0.071

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 0VF9?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders6,566,8952.39%
Institutions27,712,87910.1%
Public Companies85,286,52431%
General Public155,249,94056.5%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 8 shareholders own 43.51% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
31%
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
85,286,524CA$4.7m0%no data
10.1%
Eastern Capital Limited
27,712,879CA$1.5m0%14.67%
1.92%
Donald McCaffrey
5,263,266CA$289.5k0%no data
0.32%
Aaron Cann
869,755CA$47.8k6.1%no data
0.057%
Michael Sweeney
155,312CA$8.5k0%no data
0.039%
Kenneth Zuerblis
107,062CA$5.9k0%no data
0.038%
Kelly McNeill
105,000CA$5.8k0%no data
0.024%
Ewelina Kulikowski
66,500CA$3.7k0%no data